文献速递乳腺癌

妊娠时机与乳腺癌女性生存的关联

Association of the Timing of Pregnancy With Survival in Women With Breast Cancer.
PubMed 文献 · JAMA Oncol · 2017-01-01

这项基于加拿大安大略省行政数据库的回顾性队列研究纳入7553例20至45岁浸润性乳腺癌女性,比较无妊娠、乳腺癌前妊娠、妊娠相关乳腺癌及乳腺癌后妊娠者的总生存。结果显示妊娠未对乳腺癌女性生存产生不利影响,乳腺癌后6个月及以上妊娠者5年生存率最高。

要点

  • 妊娠未对乳腺癌女性生存产生不利影响。
  • 乳腺癌后6个月及以上妊娠者5年生存率96.7%,无妊娠者87.5%。
  • 乳腺癌后妊娠者年龄调整HR为0.22(95%CI 0.10-0.49,P<.001)。

核心结论

  • 妊娠未对乳腺癌女性生存产生不利影响;对于希望生育的乳腺癌幸存者,诊断后6个月及以上妊娠时死亡风险最低。

研究设计与样本

  • 基于加拿大安大略省关联卫生行政数据库的基于人群的回顾性队列研究,纳入2003年1月1日至2014年12月31日诊断的7553例20至45岁浸润性乳腺癌女性。

主要发现

  • 无妊娠组5年实际生存率为87.5%(95%CI 86.5%-88.4%),乳腺癌前妊娠组为85.3%(95%CI 82.8%-87.8%),年龄调整HR 1.03(95%CI 0.85-1.27,P=.73)。
  • 妊娠相关乳腺癌组5年实际生存率为82.1%(95%CI 78.3%-85.9%),年龄调整HR 1.18(95%CI 0.91-1.53,P=.20)。
  • 乳腺癌诊断后6个月及以上妊娠组5年实际生存率为96.7%(95%CI 94.1%-99.3%),无妊娠组为87.5%(95%CI 86.5%-88.4%),年龄调整HR 0.22(95%CI 0.10-0.49,P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Increasing numbers of women experience pregnancy around the time of, or after, a diagnosis of breast cancer. Understanding the effect of pregnancy on survival in women with breast cancer will help in the counseling and treatment of these women. OBJECTIVE: To compare the overall survival of women diagnosed with breast cancer during pregnancy or in the postpartum period with that of women who had breast cancer but did not become pregnant. DESIGN, SETTING, AND PARTICIPANTS: This population-based, retrospective cohort study linked health administrative databases in Ontario, Canada, comprising 7553 women aged 20 to 45 years at the time of diagnosis with invasive breast cancer, from January 1, 2003, to December 31, 2014. EXPOSURES: Any pregnancy in the period from 5 years before, until 5 years after, the index date of the diagnosis of breast cancer. Women were classified into the following 4 exposure groups: no pregnancy (the referent), pregnancy before breast cancer, pregnancy-associated breast cancer, and pregnancy following breast cancer. MAIN OUTCOMES AND MEASURES: Five-year actuarial survival rates for all exposure groups, age-adjusted and multivariable hazard ratios [HRs] of pregnancy for overall survival for all exposure groups, and time-dependent hazard ratios for women with pregnancy following breast cancer. RESULTS: Among the 7553 women in the study (mean age at diagnosis, 39.1 years; median, 40 years; range, 20-44 years) the 5-year actuarial survival rate was 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy, 85.3% (95% CI, 82.8%-87.8%) for women with pregnancy before breast cancer (age-adjusted hazard ratio, 1.03; 95% CI, 0.85-1.27; P = .73), and 82.1% (95% CI, 78.3%-85.9%) for women with pregnancy-associated breast cancer (age-adjusted hazard ratio, 1.18; 95% CI, 0.91-1.53; P = .20). The 5-year actuarial survival rate was 96.7% (95% CI, 94.1%-99.3%) for women who had pregnancy 6 months or more after diagnosis of breast cancer, vs 87.5% (95% CI, 86.5%-88.4%) for women with no pregnancy) (age-adjusted HR, 0.22; 95% CI, 0.10-0.49; P < .001). CONCLUSIONS AND RELEVANCE: Pregnancy did not adversely affect survival in women with breast cancer. For breast cancer survivors who wish to conceive, the risk of death is lowest if pregnancy occurs 6 months or more after diagnosis.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Iqbal J, Amir E, Rochon PA, et al. Association of the Timing of Pregnancy With Survival in Women With Breast Cancer. JAMA Oncol. 2017. PMID: 28278319. doi:10.1001/jamaoncol.2017.0248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。